Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 1999, p. 137-140, Vol. 37, No. 1
Swiss National Center for Mycobacteria,
Received 2 July 1998/Returned for modification 30 September
1998/Accepted 13 October 1998
Strand displacement amplification (SDA) technology has been
established in a fully automated system known as BDProbeTec. Target sequences of the insertion sequence IS6110 and the 16S rRNA
gene are simultaneously amplified, which thus allows the detection of Mycobacterium tuberculosis complex and, as an additional
option, of most Mycobacterium species. Detection occurs via
a chemiluminescent microwell assay that employs the simultaneous
hybridization and capture of SDA products with a biotinylated capture
probe and an alkaline phosphatase detector probe. We have evaluated the performance of the BDProbeTec system in detecting M. tuberculosis complex by testing 799 respiratory specimens and
comparing the results to those obtained by conventional diagnostic
techniques, i.e., microscopy and culture (solid and radiometric media).
M. tuberculosis was cultivated from 41 specimens, of
which 28 (68.4%) were smear positive and 13 (31.6%) were smear
negative. The overall sensitivity of the SDA assay was 97.6% (for
smear-positive specimens, 100%; for smear-negative specimens, 92.3%),
and specificity was 95.0%. After resolution of the discrepancies by
studying the patients' clinical data, sensitivity and specificity were
97.9 and 96.5%, respectively, and positive and negative
predictive values were 63.9 and 99.9%, respectively. These preliminary
data demonstrate that the BDProbeTec system has promising
performance characteristics with respiratory specimens and that it
allows the detection of M. tuberculosis complex within hours.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Performance Characteristics of the BDProbeTec System for Direct
Detection of Mycobacterium tuberculosis Complex in
Respiratory Specimens
*
Corresponding author. Mailing address: Swiss National
Center for Mycobacteria, Department of Medical Microbiology, University of Zurich, Gloriastrasse 30, 8028 Zurich, Switzerland. Phone: 41 1 634 27 86. Fax: 41 1 634 49 18. E-mail:
pfyffer{at}immv.unizh.ch.
Journal of Clinical Microbiology, January 1999, p. 137-140, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»